- 米国企業
- Vaxcyte, Inc.
Vaxcyte, Inc.PCVX
時価総額
$71億
PER
2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Research and Development Expense | - | 78 | 169 |
Acquired Manufacturing Rights | - | - | 23 |
General and administrative | - | 25 | 40 |
Total operating expenses | - | 104 | 232 |
Loss from operations | - | -104 | -232 |
Interest expense | - | 0 | 0 |
Interest income | - | 0 | 8 |
Grant income | - | 2 | 2 |
Realized gains on marketable securities | - | 0 | - |
Loss on disposal of fixed assets | - | - | -0 |
Foreign currency transaction (losses) gains | - | 2 | -1 |
Total other income (expense), net | - | 4 | 9 |
Net loss | -89 | -100 | -223 |
Earnings Per Share Basic | - | - | -3.44 |
Earnings Per Share Diluted | - | - | -3.44 |